The Oncology Institute, Inc. (TOI)
USD 0.19
(-2.0%)
USD 0.19
(-2.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 119.81 Million USD | 10.76% |
| 2022 | 108.17 Million USD | 59014.21% |
| 2021 | 183 Thousand USD | -98.47% |
| 2020 | 11.92 Million USD | 0.0% |
| 2019 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 121 Million USD | 0.98% |
| 2024 Q1 | 119.83 Million USD | 0.02% |
| 2023 Q1 | 110.03 Million USD | 1.71% |
| 2023 Q3 | 117.34 Million USD | 0.87% |
| 2023 FY | 119.81 Million USD | 10.76% |
| 2023 Q2 | 116.33 Million USD | 5.73% |
| 2023 Q4 | 119.81 Million USD | 2.1% |
| 2022 Q4 | 108.17 Million USD | 2.0% |
| 2022 FY | 108.17 Million USD | 59014.21% |
| 2022 Q3 | 106.06 Million USD | 455.29% |
| 2022 Q2 | 19.1 Million USD | 2.22% |
| 2022 Q1 | 18.68 Million USD | 10110.93% |
| 2021 FY | 183 Thousand USD | -98.47% |
| 2021 Q1 | 14.5 Million USD | 21.57% |
| 2021 Q3 | 4.89 Million USD | 0.36% |
| 2021 Q2 | 4.87 Million USD | -66.37% |
| 2021 Q4 | 183 Thousand USD | -96.26% |
| 2020 FY | 11.92 Million USD | 0.0% |
| 2020 Q4 | 11.92 Million USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.51 Billion USD | 92.069% |
| Addus HomeCare Corporation | 175.18 Million USD | 31.605% |
| AirSculpt Technologies, Inc. | 99.66 Million USD | -20.214% |
| Amedisys, Inc. | 487.21 Million USD | 75.408% |
| American Oncology Network, Inc. | 128.32 Million USD | 6.632% |
| Astrana Health, Inc. | 321.01 Million USD | 62.676% |
| Aveanna Healthcare Holdings Inc. | 1.49 Billion USD | 92.008% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 114.87 Million USD | -4.304% |
| Cryo-Cell International, Inc. | 10.89 Million USD | -999.621% |
| Cross Country Healthcare, Inc. | 5.26 Million USD | -2174.824% |
| COMPASS Pathways plc | 33.04 Million USD | -262.526% |
| DocGo Inc. | 46.49 Million USD | -157.682% |
| The Ensign Group, Inc. | 1.87 Billion USD | 93.597% |
| Healthcare Services Group, Inc. | 43.63 Million USD | -174.585% |
| InnovAge Holding Corp. | 113.03 Million USD | -5.998% |
| Assure Holdings Corp. | 14.8 Million USD | -709.287% |
| The Joint Corp. | 16.73 Million USD | -615.962% |
| LifeStance Health Group, Inc. | 511.04 Million USD | 76.555% |
| Mobile-health Network Solutions Class A Ordinary Shares | 657.13 Thousand USD | -18132.991% |
| ModivCare Inc. | 1.14 Billion USD | 89.491% |
| NewGenIvf Group Limited | 332.55 Thousand USD | -35928.844% |
| Novo Integrated Sciences, Inc. | 4.47 Million USD | -2579.437% |
| Option Care Health, Inc. | 1.16 Billion USD | 89.728% |
| P3 Health Partners Inc. | 124.64 Million USD | 3.872% |
| P3 Health Partners Inc. | 124.64 Million USD | 3.872% |
| The Pennant Group, Inc. | 329.63 Million USD | 63.652% |
| Surgery Partners, Inc. | 3.06 Billion USD | 96.087% |
| Syra Health Corp. Class A Common Stock | 248.1 Thousand USD | -48192.443% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 119.81 Million USD | 0.0% |